Vivo Opportunity Fund Holdings, L.P. - Mar 31, 2025 SCHEDULE 13G/A Report for Soleno Therapeutics, Inc. Common Stock, $0.001 par value per share (SLNO)

Filing Manager: Vivo Opportunity Fund Holdings, L.P.
Reporting Manager: Vivo Opportunity Fund Holdings, L.P.
Security: Soleno Therapeutics, Inc. Common Stock, $0.001 par value per share
Symbol: SLNO
Shares outstanding: 46M shares
Disclosed Ownership: 4.46M shares
Ownership: 9.7%
Form type: SCHEDULE 13G/A
Date filed: 3/31/2025, 08:00 PM
Date of event: Mar 31, 2025
Next filing: Aug 12, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Vivo Opportunity Fund Holdings, L.P.	9.7%	4.46M	4.46M	0	/s/ Kevin Dai	Kevin Dai\Managing Member
Vivo Opportunity, LLC	9.7%	4.46M	4.46M	0	/s/ Kevin Dai	Kevin Dai\Managing Member